Panel Discussion: Advancing Partnerships to Ensure Compliant, Scalable Solutions for Global Precision Medicine Applications
- When should biomarker advancement trigger formal CDx development efforts for harmonized drug-diagnostic co-development?
- Determining a fit-for-purpose CDx strategy aligned with clinical trial endpoints
- How can collaborative, cross-functional teams streamline CDx integration into therapeutic development, adoption and launch planning and market access?